Presence of multiple binding sites on α9α1 0 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1

被引:34
作者
Indurthi, Dinesh C. [1 ]
Pera, Elena [1 ]
Kim, Hye-Lim [1 ]
Chu, Cindy [1 ]
McLeod, Malcolm D. [2 ]
McIntosh, J. Michael [3 ,4 ,5 ]
Absalom, Nathan L. [1 ]
Chebib, Mary [1 ]
机构
[1] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[2] Australian Natl Univ, Res Sch Chem, Canberra, ACT 0200, Australia
[3] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT 84108 USA
[4] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA
[5] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA
基金
澳大利亚研究理事会;
关键词
Nicotinic acetylcholine receptors; Subunit stoichiometry; alpha-Conotoxins; Vc1.1; RgIA; Alpha9alpha10; NICOTINIC ACETYLCHOLINE-RECEPTOR; GAMMA-AMINOBUTYRIC-ACID; CALCIUM-CHANNELS; PHARMACOLOGICAL-PROPERTIES; ALTERNATE STOICHIOMETRIES; ALPHA-4-ALPHA-4; INTERFACE; DIFFERENTIAL SENSITIVITY; SENSORY NEURONS; SUBUNIT; RAT;
D O I
10.1016/j.bcp.2014.02.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels involved in fast synaptic transmission. nAChRs are pentameric receptors formed from a combination of different or similar subunits to produce heteromeric or homomeric channels. The heteromeric, alpha 9 alpha 10 nAChR subtype is well-known for its role in the auditory system, being expressed in cochlear hair cells. These nAChRs have also been shown to be involved in immune-modulation. Antagonists of a alpha 9 alpha 10 nAChRs, like the alpha-conotoxin Vc1.1, have analgesic effects in neuropathic pain. Unlike other nAChR subtypes there is no evidence that functional receptor stoichiometries of alpha 9 alpha 10 exist. By using 2-electrode voltage clamp methods and maintaining a constant intracellular Ca2+ concentration, we observed a biphasic activation curve for ACh that is dependent on receptor stoichiometry.Vc1.1, but not the alpha 9 alpha 10 antagonists RgIA or atropine, inhibits ACh-evoked currents in a biphasic manner. Characteristics of the ACh and Vc1.1 activation and inhibition curves can be altered by varying the ratio of alpha 9 and alpha 10 mRNA injected into oocytes, changing the curves from biphasic to monophasic when an excess of alpha 10 mRNA is used. These results highlight the difference in the pharmacological profiles of at least two different alpha 9 alpha 10 nAChR stoichiometries, possibly (alpha 9)(3)(alpha 10)(2) and (alpha 9)(2)(alpha 10)(3). As a result, we infer that there is an additional binding site for ACh and Vc1.1 at the alpha 9-alpha 9 interface on the hypothesized (alpha 9)(3)(alpha 10)(2) nAChR, in addition to the alpha 10-alpha 9 and or alpha 9-alpha 10 interfaces that are common to both stoichiometries. This study provides further evidence that receptor stoichiometry contributes another layer of complexity in understanding Cys-loop receptors. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:131 / 140
页数:10
相关论文
共 52 条
[31]   Structure and gating mechanism of the acetylcholine receptor pore [J].
Miyazawa, A ;
Fujiyoshi, Y ;
Unwin, N .
NATURE, 2003, 423 (6943) :949-955
[32]   Non-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the α4β2 nicotinic receptor:: An α4-α4 interface is required for Zn2+ potentiation [J].
Moroni, Mirko ;
Vijayan, Ranjit ;
Carbone, Anna ;
Zwart, Ruud ;
Biggin, Philip C. ;
Bermudez, Isabel .
JOURNAL OF NEUROSCIENCE, 2008, 28 (27) :6884-6894
[33]   α4β2 nicotinic receptors with high and low acetylcholine sensitivity:: Pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine [J].
Moroni, Mirko ;
Zwart, Ruud ;
Sher, Emanuele ;
Cassels, Bruce K. ;
Bermudez, Isabel .
MOLECULAR PHARMACOLOGY, 2006, 70 (02) :755-768
[34]   Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors [J].
Nelson, ME ;
Kuryatov, A ;
Choi, CH ;
Zhou, Y ;
Lindstrom, J .
MOLECULAR PHARMACOLOGY, 2003, 63 (02) :332-341
[35]   Are α9α10 nicotinic acetylcholine receptors a pain target for α-conotoxins? [J].
Nevin, S. T. ;
Clark, R. J. ;
Klimis, H. ;
Christie, M. J. ;
Craik, D. J. ;
Adams, D. J. .
MOLECULAR PHARMACOLOGY, 2007, 72 (06) :1406-1410
[36]   Characterization of the human nicotinic acetylcholine receptor subunit alpha (α) 9 (CHRNA9) and alpha (α) 10 (CHRNAIO) in lymphocytes [J].
Peng, HS ;
Ferris, RL ;
Matthews, T ;
Hiel, H ;
Lopez-Albaitero, A ;
Lustig, LR .
LIFE SCIENCES, 2004, 76 (03) :263-280
[37]   Molecular modeling of the α9α10 nicotinic acetylcholine receptor subtype [J].
Perez, Edwin G. ;
Cassels, Bruce K. ;
Zapata-Torres, Gerald .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (01) :251-254
[38]   Stoichiometry of the α9α10 nicotinic cholinergic receptor [J].
Plazas, PV ;
Katz, E ;
Gomez-Casati, ME ;
Bouzat, C ;
Elgoyhen, AB .
JOURNAL OF NEUROSCIENCE, 2005, 25 (47) :10905-10912
[39]   The α9 nicotinic acetylcholine receptor shares pharmacological properties with type a γ-aminobutyric acid, glycine, and type 3 serotonin receptors [J].
Rothlin, CV ;
Katz, E ;
Verbitsky, M ;
Elgoyhen, AB .
MOLECULAR PHARMACOLOGY, 1999, 55 (02) :248-254
[40]   Ca2+-dependent interaction of BAPTA with phospholipids [J].
Rousset, M ;
Cens, T ;
Van Mau, N ;
Charnet, P .
FEBS LETTERS, 2004, 576 (1-2) :41-45